Details for Patent: 11,446,380
✉ Email this page to a colleague
Which drugs does patent 11,446,380 protect, and when does it expire?
Patent 11,446,380 protects OXLUMO and is included in one NDA.
This patent has sixty-one patent family members in forty countries.
Summary for Patent: 11,446,380
| Title: | Compositions and methods for inhibition of HAO1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression |
| Abstract: | The invention relates to RNAi agents, e.g., double-stranded RNAi agents, targeting the HAO1 gene, and methods of using such RNAi agents to inhibit expression of HAO1 and methods of treating subjects having, e.g., PH1. |
| Inventor(s): | Querbes; William (Boston, MA), Fitzgerald; Kevin (Brookline, MA), Bettencourt; Brian (Groton, MA), Liebow; Abigail (Somerville, MA), Erbe; David V. (Arlington, MA) |
| Assignee: | Alnylam Pharmaceuticals, Inc. (Cambridge, MA) |
| Application Number: | 16/673,863 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Compound; |
Drugs Protected by US Patent 11,446,380
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alnylam Pharms Inc | OXLUMO | lumasiran sodium | SOLUTION;SUBCUTANEOUS | 214103-001 | Nov 23, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,446,380
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 3204015 | ⤷ Sign Up | 301167 | Netherlands | ⤷ Sign Up |
| European Patent Office | 3204015 | ⤷ Sign Up | PA2022004 | Lithuania | ⤷ Sign Up |
| European Patent Office | 3204015 | ⤷ Sign Up | CA 2022 00011 | Denmark | ⤷ Sign Up |
| European Patent Office | 3204015 | ⤷ Sign Up | 2022C/509 | Belgium | ⤷ Sign Up |
| European Patent Office | 3204015 | ⤷ Sign Up | LUC00252 | Luxembourg | ⤷ Sign Up |
| European Patent Office | 3204015 | ⤷ Sign Up | 122022000018 | Germany | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
